Paul Rickey
2019
In 2019, Paul Rickey earned a total compensation of $809.5K as Senior Vice President and Chief Financial Officer at Nivalis Therapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,788 |
|---|---|
| Option Awards | $319,757 |
| Salary | $370,000 |
| Total | $809,545 |
Rickey received $370K in salary, accounting for 46% of the total pay in 2019.
Rickey also received $119.8K in non-equity incentive plan and $319.8K in option awards.
Rankings
In 2019, Paul Rickey's compensation ranked 10,172nd out of 13,971 executives tracked by ExecPay. In other words, Rickey earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,172 out of 13,971 | 27th |
Division Manufacturing | 4,115 out of 5,701 | 28th |
Major group Chemicals And Allied Products | 1,570 out of 2,200 | 29th |
Industry group Drugs | 1,345 out of 1,886 | 29th |
Industry Pharmaceutical Preparations | 1,001 out of 1,398 | 28th |
Source: SEC filing on May 5, 2020.
Rickey's colleagues
We found two more compensation records of executives who worked with Paul Rickey at Nivalis Therapeutics in 2019.